Axon Enterprise, Inc. (NASDAQ:AXON) Stock Holdings Increased by GAMMA Investing LLC

GAMMA Investing LLC raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 32.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,300 shares of the biotechnology company’s stock after buying an additional 315 shares during the period. GAMMA Investing LLC’s holdings in Axon Enterprise were worth $773,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in AXON. Groupama Asset Managment bought a new stake in shares of Axon Enterprise during the 3rd quarter worth $200,000. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise during the third quarter valued at $120,553,000. International Assets Investment Management LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $871,860,000. Westfield Capital Management Co. LP increased its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, 1832 Asset Management L.P. raised its holdings in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the transaction, the director now directly owns 26,259 shares in the company, valued at approximately $11,500,916.82. The trade was a 3.67 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 51,545 shares of company stock worth $31,159,317. 6.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Northland Securities lifted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Needham & Company LLC increased their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. The Goldman Sachs Group raised their target price on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Trading Up 0.8 %

Shares of NASDAQ:AXON opened at $601.06 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $45.83 billion, a PE ratio of 155.31, a P/E/G ratio of 14.19 and a beta of 1.04. Axon Enterprise, Inc. has a 1 year low of $241.72 and a 1 year high of $698.67. The firm has a fifty day moving average price of $593.68 and a 200 day moving average price of $440.17.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.